首页> 外国专利> HEMATOLOGICAL PREDICTION OF SEPSIS AND OTHER DISEASE STATES

HEMATOLOGICAL PREDICTION OF SEPSIS AND OTHER DISEASE STATES

机译:脓毒症和其他疾病的血液学预测

摘要

A new diagnostic procedure employing a prepacked assay kit to enable the hematological prediction of cancer, sepsis, AIDS and other pathologic states is described. The kits are composed of sterile plastic test tubes and caps wherein a control tube contains an appropriate amount of physiologic saline, and an activated tube contains various activators of specific pathways of blood coagulation, e.g. endotoxins dissolved in the same volume of saline. Upon the addition of a patient's citrated whole blood (CWB) to each tube, incubation and measurement of recalcification times (RT) are performed. A ratio of the control sample RT divided by the activated samples (endotoxin) RT yields a thrombotic index (Ti), the values of which are related to various disease states. Low numerical values of this index (if endotoxin is the activating material at 10µg/cc CWB) indicate post surgical patients at high risk for sepsis (TIµ1.60); values above 1.60 indicate post-surgical patients at low risk for sepsis. Normal volunteers have values ranging from 1.15 - 1.53 whereas newly diagnosed cancer patients have values of 1.62 to 4.39 or higher.
机译:描述了一种新的诊断程序,该程序采用预装的测定试剂盒来进行癌症,败血症,AIDS和其他病理状态的血液学预测。试剂盒由无菌塑料试管和盖组成,其中对照管包含适量的生理盐水,而激活的管包含各种特定凝血途径的激活剂,例如:内毒素溶解在相同体积的盐水中。将患者的柠檬酸全血(CWB)添加到每个试管后,进行孵育和重新钙化时间(RT)的测量。对照样品RT除以活化样品(内毒素)RT的比例可得出血栓指数(Ti),其值与各种疾病状态相关。该指数的数值较低(如果内毒素是10µg / cc CWB的活化材料),则表明手术后患者有败血症的高风险(TIµ1.60)。高于1.60的值表示术后败血症风险较低的患者。正常志愿者的数值在1.15至1.53之间,而新诊断的癌症患者的数值在1.62至4.39或更高。

著录项

  • 公开/公告号IL70996A

    专利类型

  • 公开/公告日1987-12-31

    原文格式PDF

  • 申请/专利权人 UNIV NEW JERSEY MED;

    申请/专利号IL19840070996

  • 发明设计人

    申请日1984-02-17

  • 分类号G01N33/86;

  • 国家 IL

  • 入库时间 2022-08-22 06:59:54

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号